Tech Company Financing Transactions

Ceregene Funding Round

Ceregene, operating out of San Diego, secured $11.5 million from Alta Partners, Hamilton BioVentures and Investor Growth Capital.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

9381 Judicial Dr. 130
San Diego, CA 92121
USA

Phone

(858) 458-8800

Website

www.ceregene.com

Email Address

[email protected]

Overview

Using gene therapy delivery systems, Ceregene's primary focus is the discovery and development of novel genetic therapeutics for the treatment of neurological disorders. Ceregene aims to be the leader in the field of Central Nervous System (CNS) disease treatment using molecular medicine, an area of great unmet medical need.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Ostrove

        

Chief Scientific Officer

Raymond Bartus

        

Controller

Carolyn Bonebright

        

Browse more venture capital transactions:

Prev: 11/11/2010: Angie's List venture capital transaction
Next: 11/11/2010: Airbnb venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary